Skip to main content
. 1999 Jun;154(6):1793–1804. doi: 10.1016/S0002-9440(10)65435-1

Figure 5.

Figure 5

In situ detection of LAM in the lesional skin of a MB patient with ENL after treatment. A section of the lesion of a MB patient experiencing an ENL 2 years after being released from treatment (BI 0?1+) stained with the MAb to LAM. Immunoperoxidase single staining, hematoxylin counterstaining; magnification, ×80.